Human medicines European public assessment report (EPAR): Simponi, golimumab, Arthritis, Psoriatic,Spondylitis, Ankylosing,Colitis, Ulcerative,Arthritis, Rheumatoid, Date of authorisation: 01/10/2009, Revision: 36, Status: Authorised

Author(s):  
Sign in / Sign up

Export Citation Format

Share Document